Sign in to confirm you’re not a bot
This helps protect our community. Learn more

Cell therapy uncovered: pioneering TCR-Ts to target neoantigens in cancer treatment

astrazeneca
18.2K subscribers
371 views 4 months ago
We’re creating T cell receptor therapies to recognise and target cancer-associated mutations, including patient-specific neoantigens. Our T cell receptor therapies unlock new targets in cancer biology, including intracellular proteins. Learn more about our pioneering discovery platform and ambition for T cell receptor therapies: https://learn.az/6059aCfaR ------------------------------------------------------------ Global site: https://learn.az/6050aCfar Careers site: https://learn.az/6051aCfaT Follow us: Twitter: https://learn.az/6052aCfap LinkedIn: https://learn.az/6053aCfaV Instagram: https://learn.az/6054aCfan Facebook: https://learn.az/6055aCfaX ...more
...more
Cell therapy uncovered: pioneering TCR-Ts to target neoantigens in cancer treatment
3Likes
371Views
Jan 232025
We’re creating T cell receptor therapies to recognise and target cancer-associated mutations, including patient-specific neoantigens. Our T cell receptor therapies unlock new targets in cancer biology, including intracellular proteins. Learn more about our pioneering discovery platform and ambition for T cell receptor therapies: https://learn.az/6059aCfaR ------------------------------------------------------------ Global site: https://learn.az/6050aCfar Careers site: https://learn.az/6051aCfaT Follow us: Twitter: https://learn.az/6052aCfap LinkedIn: https://learn.az/6053aCfaV Instagram: https://learn.az/6054aCfan Facebook: https://learn.az/6055aCfaX

Follow along using the transcript.

astrazeneca

18.2K subscribers